New respiratory syncytial virus vaccine shows promise in Phase I trial

Micrograph of human respiratory syncytial virus virions (colourised blue) and labelled with anti-RSV F protein/gold antibodies (colourised yellow). Credit: NIAID.



  • New RSV vaccine shows promise in Phase I trial